Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01626196
Other study ID # NIT MOV 1002
Secondary ID
Status Completed
Phase N/A
First received June 20, 2012
Last updated July 10, 2012
Start date February 2012
Est. completion date June 2012

Study information

Verified date July 2012
Source Norgine
Contact n/a
Is FDA regulated No
Health authority Italy: Ministry of Health
Study type Observational

Clinical Trial Summary

Several factors are important in achieving a successful colonoscopy, including patient acceptability of the bowel cleansing procedure and the overall quality of cleansing.

This observational study has been designed to explore the main determinants of acceptability of the bowel cleansing procedure to the patient in an Italian "real life" setting. In addition, the study is to examine the determinants of quality of bowel cleansing and describe aspects of the technical performance of the colonoscopy (time to reach the caecum and adenoma detection rate).


Recruitment information / eligibility

Status Completed
Enrollment 600
Est. completion date June 2012
Est. primary completion date June 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Written informed consent obtained prior to inclusion.

- Male and female outpatients, aged = 18, treated with bowel cleansing preparation the day before undergoing routine colonoscopy at selected participating centres.

Exclusion Criteria:

- Children and adolescents aged less than 18 years. Pregnant or breastfeeding women.

- Listed contra-indications to the relevant product used for the bowel cleansing procedure.

- Patients having been submitted to a previous colonoscopy over the last five years.

- Patients who have taken laxative enemas the day preceding the colonoscopy.

Study Design

Observational Model: Ecologic or Community, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
No intervention
This was an observational study

Locations

Country Name City State
Italy IRCCS Instituto Clinico Humanitas Milan Rozzano

Sponsors (1)

Lead Sponsor Collaborator
Norgine

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patients acceptability of the procedure One day No
Secondary Time to reach the caecum One day No
Secondary Adenoma detection rate One day No